MK

Mohammad Kalamunnisa

Active Director Director DIN 01676626
DIN 01676626 First appointment Aug 2007 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Kalamunnisa

Data last updated:

Mohammad Kalamunnisa is a Director at Royal Medpharma India Private Limited (since 2007). The company operates in Chemicals.

DIN 01676626
Primary Designation Director
Industry Chemicals
First Appointment 09 Aug 2007
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20072007Active

Board colleagues of Mohammad Kalamunnisa

Directorship timeline

Open interactive timeline →
Royal Medpharma India Private Limited
Premium access

Shareholding and investment profile for Mohammad Kalamunnisa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Kalamunnisa

Mohammad Kalamunnisa currently holds 1 directorship: Royal Medpharma India Private Limited (Director, since 09 Aug 2007).

Mohammad Kalamunnisa was first appointed on 09 Aug 2007 as Director at Royal Medpharma India Private Limited.

The current boards of Mohammad Kalamunnisa's companies include Mohammad Javeed (Royal Medpharma India Private Limited), Mohammad Shaheen (Royal Medpharma India Private Limited), Salma Haseen (Royal Medpharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available